Back | Next |
home / stock / autl / autl message board
Subject | By | Source | When |
---|---|---|---|
and the shorts continue | jondoeuk | investorshub | 04/18/2023 12:24:10 AM |
The gaining | jondoeuk | investorshub | 04/17/2023 3:17:11 AM |
what do you make of this data? | jondoeuk | investorshub | 04/14/2023 3:35:15 AM |
MomentumIts trading last trade up | jondoeuk | investorshub | 04/13/2023 9:43:29 AM |
short squeeze all day | ClayTrader | investorshub | 04/12/2023 1:04:29 PM |
Price trading | jondoeuk | investorshub | 04/12/2023 3:17:50 AM |
Preclinical data https://www.cell.com/molecular-therapy-family/molecular-therapy | jondoeuk | investorshub | 03/22/2023 7:53:35 PM |
rusi: is no one intersted in this company? | rusi | investorshangout | 03/07/2023 10:46:59 AM |
New preclinical data https://www.biorxiv.org/content/10.1101/2023.02.22.529492v1 | jondoeuk | investorshub | 03/05/2023 12:24:15 AM |
ASH abstracts | jondoeuk | investorshub | 11/03/2022 5:41:41 PM |
Some slides https://clin.larvol.com/trial-detail/NCT04384393 | jondoeuk | investorshub | 09/22/2022 12:30:46 AM |
I found out that a Chinese group | jondoeuk | investorshub | 09/22/2022 12:26:07 AM |
PR https://www.globenewswire.com/news-release/2022/06/10/2460244/0/en/Autolus-Th | jondoeuk | investorshub | 06/13/2022 9:14:55 PM |
Webcast https://edge.media-server.com/mmc/p/9hqfvps4 | jondoeuk | investorshub | 06/08/2022 11:47:19 PM |
I found this | jondoeuk | investorshub | 05/19/2022 8:00:53 PM |
EHA PR https://www.globenewswire.com/news-release/2022/05/12/2442194/0/en/Autolu | jondoeuk | investorshub | 05/12/2022 6:23:42 PM |
1105: CAR-T Cells Engineered to Express a FAS-CD40 | jondoeuk | investorshub | 05/02/2022 9:41:55 PM |
ASGCT titles: | jondoeuk | investorshub | 04/29/2022 11:23:57 PM |
Also, clinical data from AUTO4*. | jondoeuk | investorshub | 04/17/2022 10:21:53 PM |
Additional clinical data at the EHA Congress, June: | jondoeuk | investorshub | 04/17/2022 10:19:30 PM |
News, Short Squeeze, Breakout and More Instantly...
Autolus Therapeutics plc Company Name:
AUTL Stock Symbol:
NASDAQ Market:
LONDON, April 24, 2024 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (NASDAQ:AUTL), a clinical-stage biopharmaceutical company developing next-g...
LONDON, April 24, 2024 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces that the abstract for longer-term follow-up and additional data analysis from the pivotal Pha...
LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its first quarter 2024 financial results and operational highlights befo...